Sort   by:  
 Page size 
UnknownSustainability and Justice: Challenges and Opportunities for an Open STEM Education.
Not available
S-EPMC9582817 | biostudies-literature
UnknownRituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma.
Not available
S-EPMC3646314 | biostudies-literature
UnknownPhase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
Not available
S-EPMC5791843 | biostudies-literature
UnknownThe impact of national cancer awareness campaigns for bowel and lung cancer symptoms on sociodemographic inequalities in immediate key symptom awareness and GP attendances.
Not available
S-EPMC4385971 | biostudies-literature
UnknownCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Not available
S-EPMC3090745 | biostudies-literature
UnknownHuman CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naive and memory NY-ESO-1-specific CD8+ T cells.
Not available
S-EPMC7394304 | biostudies-literature
UnknownAn Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis.
Not available
S-EPMC10024548 | biostudies-literature
UnknownStructural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W.
Not available
S-EPMC11430725 | biostudies-literature
UnknownGenome-wide association interaction analysis for Alzheimer's disease.
Not available
S-EPMC4370231 | biostudies-literature
UnknownAvelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study.
Not available
S-EPMC8613117 | biostudies-literature
Sort   by:  
 Page size